HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis: a randomized, placebo-controlled study in postmenopausal women

Vogelvang, T.E.; Leurs, J.R.; Mijatovic, V.; Willemse, J.; van der Mooren, M.J.

doi:10.1111/J.1538-7836.2005.01306.X

Publication

Title

HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis: a randomized, placebo-controlled study in postmenopausal women

Author

Vogelvang, T.E.

Leurs, J.R.

Mijatovic, V.

Willemse, J.

van der Mooren, M.J.

Language

English

Source (journal)

Journal of thrombosis and haemostasis. - Oxford

Publication

Oxford : 2005

ISSN

1538-7933

Volume/pages

3:5(2005), p. 1090-1092

ISI

000229132000043

Note

Letter to the editor

Full text (Publisher's DOI)

https://doi.org/10.1111/J.1538-7836.2005.01306.X

UAntwerpen

Faculty/Department				Faculty of Pharmaceutical, Biomedical and Veterinary Sciences. Pharmacy Faculty of Pharmaceutical, Biomedical and Veterinary Sciences . Biomedical Sciences

Research group				Medical Biochemistry
Publication type				L1 Letter to the editor

Affiliation				Publications with a UAntwerp address

External links

Web of Science

View record in Web of Science®

View citing articles in Web of Science®

Record

Identification

Creation

08.10.2008

Last edited

14.02.2021

To cite this reference

https://hdl.handle.net/10067/522270151162165141